Adrian C. Williams - Concepedia

Author

Adrian C. Williams

Queen Elizabeth Hospital Birmingham ORCID

Also Known As

A C Williams, A Williams, A. C. WILLIAMS, A. C. Williams, A.C Williams, A.C. WILLIAMS, A.C. Williams, A.C. Williams,, Adrian C Williams, Adrian C. WILLIAMS

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Queen Elizabeth Hospital Birmingham University of Birmingham Queen Elizabeth Hospital University College London Birmingham General Hospital

About

Adrian C. Williams is an author at Queen Elizabeth Hospital Birmingham specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	1.7K
2	Natural Sciences	4	4	100
3	Health Sciences	3	3	58
4	Social Sciences	3	3	328
5	Engineering	1	1	15

Adrian C. Williams

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease M. T. E. Heafield, Simon Fearn, Glyn B. Steventon, Neuroscience Letters Alzheimer's DiseaseMedicineDementiaSulphate LevelsNeuropharmacology	1990	445
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease Colin Smith, C. Roland Wolf, A C Gough, The Lancet Mendelian DisorderParkinson DiseaseGenetic EpidemiologyHuman PolymorphismPathology	1992	421
RAISED CEREBROSPINAL-FLUID COPPER CONCENTRATION IN PARKINSON'S DISEASE Hardev Pall, D R Blake, John M.C. Gutteridge, The Lancet NeurophysiologyCerebrospinal FluidParkinson DiseaseNeurological DisorderNeurology	1987	224
High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson's disease Richard B. Parsons, Stuart W. Smith, R. H. Waring, Neuroscience Letters Idiopathic ParkinsonMedicineParkinson DiseaseNicotineHigh Expression	2003	95
Expression of Nicotinamide N-Methyltransferase (E.C. 2.1.1.1) in the Parkinsonian Brain Richard B. Parsons, Marie-Louise Smith, Adrian C. Williams, Journal of Neuropathology & Experimental Neurology Neurodegenerative DiseasesMolecular NeuroscienceNnmt ExpressionMedicineParkinson Disease	2002	92
GABA-mediated changes in inter-hemispheric beta frequency activity in early-stage Parkinson’s disease Stephen D. Hall, Emma J. Prokic, Craig McAllister, Neuroscience	2014	62
XENOBIOTIC METABOLISM IN MOTORNEURON DISEASE Glyn B. Steventon, R. H. Waring, Adrian C. Williams, The Lancet Neurodegenerative DiseasesNeuroprotectionNeurologyNeuroscienceMolecular Neurobiology	1988	53
The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease Alexandre Castro‐Caldas, P. J. Delwaide, Wolfgang H. Jost, Movement Disorders	2005	53
Human cysteine dioxygenase type I: primary structure derived from base sequencing of cDNA Karen P. McCann, Mohammed T. Akbari, Adrian C. Williams, Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology Base SequencingAldehyde DehydrogenaseBiochemistryPrimary StructureNatural Sciences	1994	44
Human brain cytochrome P450 1B1: immunohistochemical localization in human temporal lobe and induction by dimethylbenz(a)anthracene in astrocytoma cell line (MOG-G-CCM) Carlos Roberto de Mello Rieder, Richard B. Parsons, N J Fitch, Neuroscience Letters Neuro-oncologyImmunohistochemical LocalizationGliomaEpendymaMedicine	2000	39

Page 1